ArriVent Biopharma Investor Call Presentation
9/24
ArriVent Biopharma Corporate Presentation August 2025
9/24
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
8/11
Statement of Changes in Beneficial Ownership (Form 4)
7/15
Supplemental Prospectus (Form 424B5)
7/2
Supplemental Prospectus (Form 424B5)
7/1
Statement of Changes in Beneficial Ownership (Form 4)
6/20
Statement of Changes in Beneficial Ownership (Form 4)
6/20
Statement of Changes in Beneficial Ownership (Form 4)
6/20
Statement of Changes in Beneficial Ownership (Form 4)
6/20